Found: For example, early-onset multiple sclerosis is a disease that is particularly prominent among women

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether the NHS is taking steps with (a) technology developers and (b) academia to help accelerate the introduction of innovative medical solutions.

Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)

In February 2023, the Department published the MedTech strategy which outlined how we will work with key stakeholders, including technology developers and academia, to ensure the health and social care system can reliably access safe, effective, and innovative medical technologies. To accelerate the introduction of innovative medical solutions, we are working with stakeholders at pace to implement solutions to streamline and join-up the innovation adoption pathway, from providing clear signals to industry on the innovation we need, to reforming regulation, comparative assessment, and with clearer procurement pathways.

In October 2023, the Government announced £30 million of investment in the Health Tech Adoption and Acceleration Fund. The fund is supporting integrated care systems to invest in the latest technology to help cut waiting lists, speed up diagnosis, and deliver new and improved ways to treat patients. Thanks to this fund, tens of thousands of patients at risk of kidney disease will be able to get tested from the comfort of their own homes. In February 2024, the Government announced eight innovative tech companies who will be supported to bring their devices to market through the Innovative Devices Access Pathway (IDAP). One of the technologies allows chemotherapy patients to self-test at home, using a finger-prick blood test, for neutropenic sepsis. Another is a smartphone app that delivers exercises, cognitive behaviour therapy, and targeted physical activity in a personally customisable format to help patients manage multiple sclerosis.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps her Department is taking to help encourage innovation in the development of healthcare technology for at home use.

Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)

In February 2023, the Department published the MedTech strategy which outlined how we will work with key stakeholders, including technology developers and academia, to ensure the health and social care system can reliably access safe, effective, and innovative medical technologies. To accelerate the introduction of innovative medical solutions, we are working with stakeholders at pace to implement solutions to streamline and join-up the innovation adoption pathway, from providing clear signals to industry on the innovation we need, to reforming regulation, comparative assessment, and with clearer procurement pathways.

In October 2023, the Government announced £30 million of investment in the Health Tech Adoption and Acceleration Fund. The fund is supporting integrated care systems to invest in the latest technology to help cut waiting lists, speed up diagnosis, and deliver new and improved ways to treat patients. Thanks to this fund, tens of thousands of patients at risk of kidney disease will be able to get tested from the comfort of their own homes. In February 2024, the Government announced eight innovative tech companies who will be supported to bring their devices to market through the Innovative Devices Access Pathway (IDAP). One of the technologies allows chemotherapy patients to self-test at home, using a finger-prick blood test, for neutropenic sepsis. Another is a smartphone app that delivers exercises, cognitive behaviour therapy, and targeted physical activity in a personally customisable format to help patients manage multiple sclerosis.

Found: (3), or in regulation 53(1)(a) to (b)”. (11) Omit Part 10 (standing rules: funding of therapies for Multiple

Found: For example, Multiple Sclerosis (MS) is a focus of the research in this project.

Found: Some conditions are automatically considered disabilities, such as cancer, HIV infection and multiple

Found: Some conditions are automatically considered disabilities, such as cancer, HIV infection and multiple

Found: In March 2017 he was diagnosed with multiple sclerosis.

Found: Multiple Sclerosis Gene tics Consortium 2007 , International Multiple Sclerosis Genetics Consortium

Found: Sensory distu rbance (336), Sensory loss (291), Neuropathy peripheral (263), Myelitis transverse (86), Multiple

Found: Disturbance in attention 3 0 Migraine headaches Migraine 23 0 Migraine without aura 1 0 Multiple

Found: variation to extend the therapeutic indication for Tecfidera to include treatment of relapsing remitting multiple

Found: Sclerosis MSSR Monthly Summary Safety Report NA Neuralgic Amyotrophy NAbs Neutralizing Antibodies

Found: types 1 and 2 Chronic Neurological diseases Generalised convulsions Dementia Demyelination multiple

Found: Exertional headache 1 External compression headache 1 Thunderclap headache 1 Tongue paralysis 1 Multiple

Found: sclerosis No Hemiplegia No Parkinson’s disease No Neuron motor disease No Down's syndrome No

Found: and 2 Yes Chronic Neurological diseases Generalised convulsions No Dementia No Demyelination multiple

Found: Additionally, the Scottish Ballet runs a specific programme for individuals with multiple sclerosis